Related Experiment Videos
[Chronic recurrent multifocal osteomyelitis. A diagnosis to be called to mind]
C Saint-Martin1, I Kurelovic, J Durckel
1Département de Radiologie et Imagerie, UCL Cliniques Saint-Luc, Bruxelles, Belgique.
Journal De Radiologie
|February 1, 1997
Summary
Chronic recurrent multifocal osteomyelitis (CRMO) is a rare bone disorder in children and teens, presenting with recurrent bone pain and swelling. Early diagnosis and treatment with NSAIDs are key for managing this benign, self-limited condition.
Area of Science:
- Pediatric Rheumatology
- Orthopedic Surgery
- Dermatology
Background:
- Chronic recurrent multifocal osteomyelitis (CRMO) is a rare inflammatory bone disorder predominantly affecting children and adolescents.
- It typically manifests with insidious onset of localized swelling and pain in multiple metaphyses, often with a symmetric and recurrent pattern.
- CRMO can be associated with cutaneous conditions like palmoplantar pustulosis or acne fulminans, and less commonly with inflammatory bowel disease.
Purpose of the Study:
- To summarize the clinical characteristics, pathogenesis, diagnostic considerations, and management of chronic recurrent multifocal osteomyelitis.
- To highlight the importance of differentiating CRMO from infectious osteomyelitis and bone tumors.
- To provide an overview of the typical disease course and treatment efficacy.
Main Methods:
- Literature review of CRMO cases and established etiological theories.
- Analysis of clinical presentation, including typical and atypical manifestations.
- Discussion of diagnostic procedures, emphasizing biopsy and culture for differential diagnosis.
Main Results:
- CRMO is characterized by recurrent, multifocal bone lesions, primarily in metaphyses, with possible spinal involvement.
- Pathogenesis is often linked to enthesopathy, where enthesitis progresses to aseptic osteomyelitis.
- Biopsy with culture is crucial to exclude bacterial infection and malignancy, especially in solitary bone lesions.
Conclusions:
- CRMO follows a benign, self-limited course with recurrences and remissions over 6-10 years.
- Non-steroidal anti-inflammatory drugs (NSAIDs) are generally effective for treatment.
- Prompt diagnosis and appropriate management are essential for favorable outcomes in pediatric patients with CRMO.